Book and thesis
Papers
Phase 1 Clinical Trial of PPMX-T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate its Safety, Pharmacokinetics, and Pharmacodynamics Clinical Pharmacology in Drug Development,pp.579-587 2023/06
Papers
PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development Communications Biology 5 (1),pp.961 2022/09/14
Papers
A novel RARA–SNX15 fusion in PML–RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1) International Journal of Hematology 116,pp.956-960 2022/07/19
Papers
CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma Blood Advances 6 (11),pp.3230-3233 2022/06/14
Papers
新規融合遺伝子RARA-SNX15を伴った急性前骨髄球性白血病の一例(A novel fusion transcript RARA-SNX15 in an APL case harboring t(11;17;15)(q13;q21.2;q24.1)) 日本血液学会学術集会 83回,pp.OS3-3 2021/09
Papers
Truncated runx1 generated by the fusion of runx1 to antisense grik2 via a cryptic chromosome translocation enhances sensitivity to granulocyte colony-stimulating factor Cytogenetic and Genome Research 160 (5),pp.255-263 2020/07/01
Papers
ETV6の再構成による異所性遺伝子発現を認めた急性骨髄性白血病の二症例(Two cases of AML with ectopic gene expression resulting from the ETV6 rearrangements) 臨床血液 59 (9),pp.1642-1642 2018/09
Papers
Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1–RUNX1T1 leukemia with t(8;12;21) International Journal of Hematology 108 (2),pp.208-212 2018/08/01
Papers
再発急性骨髄性白血病において微小転座から複数のスプライシング産物を認めたRUNX1-GRIK2融合遺伝子(Multiple splicing transcripts from RUNX1-GRIK2 fusion in a cryptic translocation in a relapsed AML) 臨床血液 58 (9),pp.1603-1603 2017/09
Papers
The prognostic significance of EBV DNA load and EBER status in diagnostic specimens from diffuse large B-cell lymphoma patients Hematological Oncology 35 (1),pp.87-93 2017/03/01
Papers
t(4;12)を伴うAML症例におけるETV6転座によるPDGFRAおよびGSX2の転写活性化(Transcriptional activation of PDGFRA and GSX2 by ETV6 translocation in a case of AML with t(4;12)) 臨床血液 57 (9),pp.1704-1704 2016/09
Papers
TP53 mutations in older adults with acute myeloid leukemia International Journal of Hematology 103 (4),pp.429-435 2016/04
Papers
Transcriptional activation of platelet-derived growth factor receptor α and GS homeobox 2 resulting from E26 transformation-specific variant 6 translocation in a case of acute myeloid leukemia with t(4;12)(q12;p13) International Journal of Laboratory Hematology 38 (2),pp.e15-e18 2016/04
Papers
ETV6-LPXN fusion transcript generated by t(11;12)(q12.1;p13) in a patient with relapsing acute myeloid leukemia with NUP98-HOXA9 Genes Chromosomes and Cancer 55 (3),pp.242-250 2016/03/01
Papers
A case of HHV-8 negative body cavity-based lymphoma (primary effusion lymphoma-like lymphoma), and clinicophathological study of 5 cases at our institution,pp.47-53 2016/02
Papers
In vitro anticancer activity of methyl caffeate isolated from Solanum torvum Swartz. fruit Chemico-Biological Interactions 242,pp.81-90 2015/12/05
Papers
NUP214-RAC1 and RAC1-COL12A1 Fusion in Complex Variant Translocations Involving Chromosomes 6, 7 and 9 in an Acute Myeloid Leukemia Case with DEK-NUP214 Cytogenetic and Genome Research 146 (4),pp.279-284 2015/12/01
Papers
Elongation of MPL Transmembrane Domain Is a Novel Activating-Mutation in Essential Thrombocythemia BLOOD 126 (23) 2015/12
Papers
Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma Cancer Science 106 (11),pp.1576-1581 2015/11/01
Papers
Bendamustineとrituximab併用による再治療の免疫系に対する有効性、毒性および影響(Efficacy, toxicity and effect on the immune system of retreatment with bendamustine plus rituximab) 臨床血液 56 (9),pp.1547-1547 2015/09
Papers
DLBCL患者の処置前血清におけるEBV DNA検出の予後的意義(Prognostic significance of EBV DNA detection in pretreatment serum from patients with DLBCL) 臨床血液 56 (9),pp.1361-1361 2015/09
Papers
MPL膜貫通領域の伸長は本態性血小板血症における新規活性化突然変異である(Elongation of MPL transmembrane domain is a novel activating-mutation in essential thrombocythemia) 臨床血液 56 (9),pp.1432-1432 2015/09
Papers
t(8;12;21)のRUNX1-RUNX1T1白血病において発見されたTM7SF4-VPS13BおよびVPS13B-RUNX1融合遺伝子(TM7SF4-VPS13B and VPS13B-RUNX1 fusion genes found in RUNX1-RUNX1T1 leukemia with t(8;12;21)) 臨床血液 56 (9),pp.1540-1540 2015/09
Papers
t(8;14;18)(q24;q32;q21)を有するDLBCLとBLの中間型リンパ腫(Intermediate lymphoma between DLBCL and BL with t(8;14;18) (q24;q32;q21)) 臨床血液 56 (9),pp.1599-1599 2015/09
Papers
導入化学療法を受けない急性骨髄性白血病患者の転帰(The fate of patients with acute myeloid leukemia not undergoing induction chemotherapy) 臨床血液 56 (9),pp.1389-1389 2015/09
Papers
The fate of patients with acute myeloid leukemia not undergoing induction chemotherapy International Journal of Hematology 102 (1),pp.35-40 2015/07/23
Papers
A case of primary cutaneous extranodal NK/T-cell lymphoma resembling CD8-positive primary cutaneous peripheral T-cell lymphoma (No period is necessary.) Skin Cancer,pp.258-263 2015/02
Papers
A Varicella Outbreak in Diffuse Large B-Cell Lymphoma Patients Receiving Rituximab-Containing Chemotherapy BLOOD 124 (21) 2014/12
Papers
CML治療中に生じた重度AA 造血細胞に対するCTLの関与の可能性(Severe AA developed during treatment of CML: Potential involvement of CTL to hematopoietic cells) 臨床血液 55 (9),pp.1423-1423 2014/09
Papers
DEK-NUP214を伴うAML患者における付加的なNUP214-RAC1融合遺伝子(Additional NUP214-RAC1 fusion gene in an AML patient with DEK-NUP214) 臨床血液 55 (9),pp.1426-1426 2014/09
Papers
びまん性大細胞型B細胞リンパ腫におけるEBV量とEBER陽性の予後的意義(The prognostic significance of EBV viral load and EBER-positivity in diffuse large B-cell lymphoma) 臨床血液 55 (9),pp.1388-1388 2014/09
Papers
Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H Gene Therapy 21 (6),pp.575-584 2014/06
Papers
Clarifying the impact of polycomb complex component disruption in human cancers Molecular Cancer Research 12 (4),pp.479-484 2014/04
Papers
A varicella outbreak in B-cell lymphoma patients receiving rituximab-containing chemotherapy Journal of Infection and Chemotherapy 20 (12),pp.774-777 2014
Papers
HLA-A2に提示されたマイナー抗原HA-1認識抗体の開発と応用(Construction and molecular characterization of a single chain antibody specific for HA-1 minor H antigen) 日本癌学会総会記事 72回,pp.353-353 2013/10
Papers
Functionally Deregulated AML1/RUNX1 Cooperates with BCR-ABL to Induce a Blastic Phase-Like Phenotype of Chronic Myelogenous Leukemia in Mice PLoS ONE 8 (9),pp.e74864 2013/09/30
Papers
第1選択R-CHOP療法が濾胞性リンパ腫患者の免疫に及ぼす影響(Effects of 1st line R-CHOP on the immunity in patients with follicular lymphoma) 臨床血液 54 (9),pp.1154-1154 2013/09
Papers
Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: A single-center experience Hematology 18 (2),pp.74-80 2013/03
Papers
A novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with a t(11;21)(p14;q22) Cancer Genetics 205 (11),pp.608-611 2012/11
Papers
INVESTIGATIN OF A DISSEMINATED VARICELLA IN LYMPHOMAPATIENT TREATED WITH RITUXIMAB COMBINED CHEMOTHERAPY ANNALS OF ONCOLOGY 23,pp.166-166 2012/10
Papers
Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy International Journal of Hematology 96 (4),pp.516-520 2012/10
Papers
NUP98-HOXA9のAML再発患者に見られたt(11;12)(q13;p13)の追加よるETV6-LPXN融合遺伝子(ETV6-LPXN fusion from additional t(11;12) (q13;p13) in a patient relapsing with AML with NUP98-HOXA9) 臨床血液 53 (9),pp.1196-1196 2012/09
Papers
リツキシマブの開発前後の無作為に選んだDLBCL患者の治療成績の違い(Differences in outcome for unselected patients with DLBCL before and after the advent of rituximab) 臨床血液 53 (9),pp.1036-1036 2012/09
Papers
HapMap SNP Scanner: An online program to mine SNPs responsible for cell phenotype Tissue Antigens 80 (2),pp.119-125 2012/08
Papers
t(X;17)(p11;q21) BCOR/RARA Atlas of Genetics and Cytogenetics in Oncology and Haematology 16 (6),pp.429-431 2012/05
Papers
Isolation of human mAbs that directly modulate FMS-related tyrosine kinase 3 signaling Cancer Science 103 (2),pp.350-359 2012/02
Papers
Successful autologous stem cell transplantation for relapsed lymphoma with peripheral blood stem cells cryopreserved for ten years. Journal of Hematopoietic Cell Transplantation 1 (1),pp.29-32 2012
Papers
Deferasiroxを投与したMDS患者2例における造血に及ぼす好ましい効果(Positive effects on hematopoiesis in two patients with MDS receiving deferasirox) 臨床血液 52 (9),pp.1331-1331 2011/09
Papers
FLT3シグナル伝達を直接調節するヒト単クローン抗体の分離(Isolation of human monoclonal antibodies directly modulating FLT3 signaling) 臨床血液 52 (9),pp.1350-1350 2011/09
Papers
t(11;21)(p14;q22)を有する急性骨髄性白血病の1症例における新しいRUNX1-C11orf41融合遺伝子(Novel RUNX1-C11orf41 fusion gene in a case of acute myeloid leukemia with t(11:21)(p14:q22)) 臨床血液 52 (9),pp.1324-1324 2011/09
Papers
血液悪性腫瘍を伴うDICに関する単施設での解析(Single center analysis of DIC with hematologicalmalignancy) 臨床血液 52 (9),pp.1178-1178 2011/09
Papers
臍帯血移植後にオセルタミビル耐性新型インフルエンザ(H1N1)感染により死亡した成人APLの1例 日本造血細胞移植学会総会プログラム・抄録集,pp.323 2011
Papers
BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia Blood 116 (20),pp.4274-4283 2010/11/18
Papers
BCOR as a Novel Fusion Partner of Retinoic Acid Receptor Alpha In a t(X;17)(p11;q12) Variant of Acute Promyelocytic Leukemia. BLOOD 116 (21),pp.713-714 2010/11
Papers
急性前骨髄球性白血病のt(X:17)(p11:q12)バリアントにおいてBCORはRARαの新しい融合パートナーである(BCOR is a novel fusion partner of RARα in a t(X:17)(p11:q12) variant of acute promyelocytic leukemia) 臨床血液 51 (9),pp.932-932 2010/09
Papers
Alteration in antibody-mediated immunity in patients with rituximab-combined chemotherapy and incidence of herpes zoster Japanese Journal of Cancer and Chemotherapy 37 (1),pp.99-102 2010/01
Papers
Fludarabine療法後に発症した細菌性髄膜炎 日本臨床腫瘍学会学術集会プログラム・抄録集,pp.284-285 2010
Papers
低悪性度B細胞リンパ腫に対するFludarabinおよびRituximab‐Fludarabin療法の有害事象;免疫機能に与える影響を中心に 日本臨床腫瘍学会学術集会プログラム・抄録集,pp.284 2010
Papers
PU.1-c-Jun Interactions Are Crucial for PU.1 Function in Myeloid Development BLOOD 114 (22),pp.1408-1408 2009/11
Papers
MP療法抵抗性の骨髄腫患者に対するゾレドロネートの抗骨髄腫作用の症例報告(A case report of anti myeloma effect of Zoledronate in MP therapy resistant patient) 臨床血液 50 (9),pp.1184-1184 2009/09
Papers
Rituximabを含む化学療法が免疫機能に与える影響 1.液体免疫能の変化についての検討 日本臨床腫瘍学会学術集会プログラム・抄録集,pp.294 2009
Papers
Rituximabを含む化学療法が免疫機能に与える影響 2.細胞性免疫能の変化についての検討 日本臨床腫瘍学会学術集会プログラム・抄録集,pp.295 2009
Papers
Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinib Internal Medicine 48 (16),pp.1433-1435 2009
Papers
末梢性T細胞リンパ腫の臨床病態と治療成績の検討 日本臨床腫瘍学会学術集会プログラム・抄録集,pp.352 2009
Papers
Chronic myeloid leukemia following chemotherapy with 5′-deoxy-5-fluorouridine for gastric cancer Internal Medicine 47 (19),pp.1739-1741 2008
Papers
Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations Journal of Experimental Medicine 203 (2),pp.371-381 2006/02/20
Papers
Differentiation block in FLT3 mutant AML by inactivation of C/EBP alpha function by phosphorylation. BLOOD 102 (11),pp.172A-172A 2003/11
Papers
Induction of monocytic differentiation by PU.1 is dependent on interaction with its co-activator, c-Jun. BLOOD 102 (11),pp.343A-343A 2003/11
Papers
ヒト血液悪性疾患におけるFLT3の活性化ループ内のD835変異の活性化(ACTIVATING MUTATION OF D835 WITHIN THE ACTIVATION LOOP OF FLT3 IN HUMAN HEMATOLOGICAL MALIGNANCIES) Nagoya Journal of Medical Science 65 (1〜2),pp.46-46 2002/05
Papers
Selective apoptosis of tandemly duplicated FLT3-transformed leukemia cells by Hsp90 inhibitors Leukemia,pp.1535-1540 2002
Papers
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies Blood 97 (8),pp.2434-2439 2001/04
Papers
FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy Cancer Chemotherapy and Pharmacology 48 (SUPPL. 1) 2001
Papers
In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD/Shi-scid/scid mice Japanese Journal of Cancer Research 92 (5),pp.529-536 2001
Papers
In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor Leukemia 14 (3),pp.374-378 2000
Papers
Efficacy of Granisetron in the Prevention of Emesis Induced by Conditioning Chemotherapy for Allogeneic Bone Marrow Transplantation. 癌と化学療法,pp.2095-2099 1998/11
Papers
Successful Treatment of a Jehovah’s Witness with Acute Promyelocytic Leukemia by All-Trans Retinoic Acid. Biotherapy (Tokyo),pp.1159-1163 1998/08
Papers
Treatment of Acute Myelogenous Leukemia in Patients More Than 80 Years Old. 癌と化学療法,pp.1089-1093 1997/07
Papers
High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in elderly patients. Medical Postgraduates,pp.107-110 1996/04
Papers
Marked Bone Marrow Necrosis Preceding Acute Monoblastic Leukemia. 癌と化学療法,pp.2111-2114 1995/12
Papers
Very Elderly AML Patient in Complete Remission More Than 8 Years with Ubenimex Maintenance Therapy. Biotherapy (Tokyo),pp.1297-1300 1995/10